A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Prediction of Treatment Entry and Completion in Prison

Journal of Offender Rehabilitation

Volumn 51, Issue 4, 2012, Pages 222-238

  Gordon, Michael S ^a,b   Kinlock, Timothy W ^a,c   Couvillion, Kathryn A ^a   Schwartz, Robert P ^a   O'Grady, Kevin ^d  

^a FRIENDS RESEARCH INSTITUTE   (United States)

^b STEVENSON UNIVERSITY   (United States)

^c UNIVERSITY OF BALTIMORE   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

criminal justice; drug treatment; heroin; methadone maintenance; prisoners

Indexed keywords

EID: 84861539096     PISSN: 10509674     EISSN: 15408558     Source Type: Journal    
DOI: 10.1080/10509674.2011.641075     Document Type: Article

References (70)

1. Agresti, A. (1990). Categorical data analysis. New York, NY: Wiley.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders DSM-IV-TR. Washington, DC: Author.
3. Chaiken, J. M., & Chaiken, M. R. (1990). Drugs and predatory crime. In M. Tonry & J. Q. Wilson (Eds.), Drugs and crime (Crime and justice: A review of research, Vol. 13, pp. 203-239). Chicago, IL: University of Chicago Press.
4. Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009). Treating drug abuse and addiction in the criminal justice system: Improving public health and safety. JAMA, 301 (2), 183-190.
5. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. (), 2nd ed.: Hillsdale, NJ.
6. Cravioto, P., Medina-Mora, M. E., de la Rosa, B., Galvan, F., & Tapia-Conyer, R. (2003). Patrones de consumo de heroina en una carcel de la frontera norte de Mexico: Barreras de acceso a tratamiento [Patterns of heroin consumption in a jail on the northern Mexican border: Barriers to treatment access.] Salud Publica de Mexico, 45, 181-190.
7. Dolan, K. A., Hall, W., & Wodak, A. (1996) Methadone maintenance reduces injecting in prison. British Medical Journal, 312, 1162.
8. Dolan, K. A., Shearer, J., MacDonald, M., Mattick, R. P., Hall, W., & Wodak, A. D. (2003). A randomized controlled trial of methadone maintenance treatment versus wait list control in an Australian Prison System. Drug and Alcohol Dependence, 72, 59-65.
9. Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005). Four-year follow-up of imprisoned male heroin users and methadone treatment: Mortality, re-incarceration, and hepatitis C infection. Addiction, 100, 820-828.
10. Dolan, K., Khoei, E. M., Brentari, C., & Stevens, A. (2007). Prison and drugs: A global review of incarceration, drug use and drug services. Oxford: Beckley Foundation.
11. Dole, V. P., Robinson, J. W., Orraca, J., Towns, E., Searcy, P., & Caine, E. (1969). Methadone treatment of randomly selected criminal addicts. New England Journal of Medicine, 280, 1372-1375.
12. Farrington, D. P. (2005). Introduction to integrated development and life-course theories of offending. In D. P. Farrington (Ed.), Integrated developmental & life-course theories of offending (Advances in criminological theory, Vol. 14, pp. 1-14). New Brunswick, NJ: Transaction Publishers.
13. Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O'Grady, K. E. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months post-release. Addiction, 103, 1333-1342.
14. Gorta, A. (1992, November). Monitoring the New South Wales methadone program: 1986-1991 (Research Publication No. 25). Sydney, Australia: NSW Department of Corrective Services.
15. Gossop, M. (2006). Treating drug misuse problems: Evidence of effectiveness. London, England: National Treatment Agency for Substance Misuse.
16. Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K.,... Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86, 1-21.
17. Hanlon, T. E., Nurco, D. N., Bateman, R. W., & O'Grady, K. E. (1998). The response of drug abuser parolees to a combination of treatment and intensive supervision. The Prison Journal, 78, 31-44.
18. Heimer, R., Catania, H., Newman, R. G., Zambrano, J., Brunet, A., & Ortiz, A. M. (2006). Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico. Drug and Alcohol Dependence, 83, 122-129.
19. Hiller, M. L., Knight, K., & Simpson, D. D. (1999). Risk factors that predict dropout from corrections-based treatment for drug abuse. The Prison Journal, 79, 411-430.
20. Hiller, M. L., Narevic, E., Webster, M. J., Rosen, P., Staton, M., Leukfeld, C., Garrity, T. F., & Kayo, R. (2009). Problem severity and motivation for treatment in incarcerated substance abusers. Substance Use and Misuse, 44, 28-41.
21. Hiller, M. L., Knight, K., Leukfeld, C. G., & Simpson, D. D. (2002). Motivation as a predictor of engagement in mandated residential substance abuse treatment. Criminal Justice and Behavior, 29(1), 56-75.
22. Hosmer, D., & Lemeshow, S. (1989). Applied logistic regression. New York, NY: Wiley.
23. Hser, Y., Huang, Y., Teruya, C., & Anglin, M. D. (2004). Gender differences in treatment outcomes over a three-year period: A path model analysis. Journal of Drug Issues, 34, 419-440.
24. Inciardi, J. (2008). The war on drugs IV., 4th ed.: Upper Saddle River, NJ.
25. Inciardi, J. A., Martin, S. S., Butzin, C. A., Hooper, R. M., & Harrison, L. D. (1997). An effective model of prison-based treatment for drug-involved offenders. Journal of Drug Issues, 27, 261-278.
26. Inciardi, J. A., Martin, S. S., & Butzin, C. A. (2004). Five-year outcomes of therapeutic community treatment of drug-involved offenders after release from prison. Crime & Delinquency, 50, 88-107.
27. Joe, G. W., Simpson, D. D., & Broome, K. M. (1998). Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction, 93, 1177-1190.
28. Joe, G. W., Simpson, D. D., & Broome, K. M. (1999). Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependence, 57 (2), 113-125.
29. Johnson, B. D., Goldstein, P., Preble, E., Schmeidler, J., Lipton, D. S., Spunt, B., & Miller, T. (1985). Taking care of business: The economics of crime by heroin abusers. Lexington, MA: Lexington Books.
30. Jurgens, R. (2004). Is the world finally waking up to HIV/AIDS in prisons? A report from the 15th International AIDS Conference. Infectious Diseases in Corrections Report, 7, 1-9.
31. Kastelic, A., Pont, J., & Stöver, H. (2008). Opioid substitution treatment in custodial settings. A practical guide. Oldenburg, Germany: BIS-Verlag.
32. Kidorf, M., Brooner, R. K., King, V. L., Stoller, K. B., & Wertz, J. (1998). Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. Journal of Consulting and Clinical Psychology, 66, 168-173.
33. Kinlock, T. W., Battjes, R. J., & Schwartz, R. P. (2002). A novel opioid maintenance program for prisoners: preliminary findings. Journal of Substance Abuse Treatment, 22 (3), 141-147.
34. Kinlock, T. W., Battjes, R. J., & Schwartz, R. P. (2005). A novel opioid maintenance program for prisoners: report of post-release outcomes. American Journal of Drug and Alcohol Abuse, 31, 433-454.
35. Kinlock, T. W., & Gordon, M. S. (2006). Substance abuse treatment: New research. In L. A. Bennett (Ed.), New topics in substance abuse treatment, (pp. 73-111). Hauppauge, NY: Nova Science Publishers.
36. Kinlock, T. W., Gordon, M. S., & Schwartz, R. P. (2011). Incarcerated populations. In P. Ruiz & E. Strain (Eds.), Lowinson & Ruiz's substance abuse: A comprehensive textbook (, 5th ed., pp. 881-891). Lippincott Williams & Wilkins.
37. Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O'Grady, K. E. (2009). A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months post-release. Journal of Substance Abuse Treatment, 37, 277-285. PMCID: PMC2803487
38. Kinlock, T. W., Gordon, M. S., Schwartz, R. P., O'Grady, K., Fitzgerald, T. T., & Wilson, M. (2007). A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91, 220-227. PMCID: PMC2423344
39. Kinlock, T. W., Gordon, M. S., Schwartz, R. P., & O'Grady, K. E. (2008). A Study of methadone maintenance for male prisoners: 3-month post-release outcomes. Criminal Justice Behavior, 35 (1), 34-47. PMCID: PMC2443939
40. Kinlock, T. W., O'Grady, K. E., & Hanlon, T. E. (2003). Prediction of the criminal activity of incarcerated drug-abusing offenders. Journal of Drug Issues, 33, 897-920.
41. Kinlock, T. W., Schwartz, R. P., & Gordon, M. S. (2005). The significance of interagency collaboration in developing opioid agonist programs for prisoners. Corrections Compendium, 30, 6-9, 28-30.
42. Kleber, H. D. (2008). Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA, 300, 2303-2305.
43. Lobmaier, P. P., Kunoe, N., & Waal, H. (2009). Treatment research in prisons: Problems and solutions in a randomized trial. Addiction Research and Theory, 1-13. iFirst.
44. Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C.,... Rosenblum, A. (2009). Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug and Alcohol Dependence, 99 (1/3), 222-230.
45. Magura, S., Nwakese, P., & Demsky, S. (1998). Pre- and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51-61.
46. Magura, S., Rosenblum, A., Lewis, C., & Joseph, H. (1993). The effectiveness of in-jail methadone maintenance. Journal of Drug Issues, 23, 75-99.
47. Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo or methadone maintenance for opiate dependence [Review]. Cochrane Database of Systematic Reviews (2), CD002207.
48. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G.,... Argeriou, M. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9 (3), 199-213.
49. Michels, I., Stover, H., & Gerlach, R. (2007). Substitution treatment for opioid addicts in Germany. Harm Reduction Journal, 2, 4-5.
50. Murphy, S. A., Lynch, K. G., Oslin, D., McKay, J. R., & Tenhave, T. (2007). Developing adaptive treatment strategies in substance abuse research. Drug and Alcohol Dependence, 88, S24-S30.
51. National Consensus Development on the Effectiveness of Medical Treatment of Opiate Addiction. (1998). National Institute of Health Consensus Conference: Effective medical treatment of opioid addiction. Journal of the American Medical Association, 280, 1936-1943.
52. Nunn, A., Zaller, N., Dickman, S., Trimbur, Nijhawan, A., & Rich, J. D. (2009). Methadone and buprenorphine prescribing and referral practices in prison systems: results from a nationwide survey. Drug and Alcohol Dependence, 105 (1-2), 83-88.
53. Nurco, D. N. (1998). A long-term program of research on drug use and crime. Substance Use and Misuse, 33, 1817-1837.
54. Office of National Drug Control Policy. (2001). The national drug control strategy annual report. Washington, DC: Author.
55. Pang, L., Hao, Y., Mi, G., Wang, C., Luo, W., Rou, K.,... Wu, Z. (2007). Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS, 21, S103-S107.
56. Peles, E., & Adelson, M. (2006). Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic. Journal of Addictive Disease, 25, 39-45.
57. Piquero, A. R., Farrington, D. P., & Blumstein, A. (2003). The criminal career paradigm. In M. Tonry (Ed.), Crime and justice: A review of research (Vol. 30, pp. 359-505). Chicago, IL: University of Chicago Press.
58. Platt, J. J., Widman, M., Lidz, V., & Marlowe, D. (1998). Methadone maintenance treatment: Its effectiveness after 30 years. In J. A. Inciardi, & L. Harrison (Eds.), Heroin in the age of crack-cocaine, (pp. 167-180). Thousand Oaks, CA: Sage.
59. Prendergast, M. L., & Wexler, H. L. (2004). Correctional substance abuse treatment programs in California: A historical perspective. The Prison Journal, 84, 8-35.
60. Rich, J. D., Boutwell, A. E., Shield, D. C., Key, R. G., McKenzie, M., Clarke, J. G., & Friedman, P. D. (2005). Attitudes and practices regarding the use of methadone in U.S. state and federal prisons. Journal of Urban Health, 82, 411-419.
61. Rowan-Szal, G. A., Chatham, L. R., Joe, G. W., & Simpson, D. D. (2000). Services provided during methadone treatment: A gender comparison. Journal of Substance Abuse Treatment, 19, 7-14.
62. Simpson, D. D., & Joe, G. W. (1993). Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy, 30, 357-368.
63. Smith-Rohrberg, D., Bruce, R. D., & Altice, F. L. (2004). Research note-Review of corrections-based therapy for opiate-dependent patients: Implications for buprenorphine treatment among correctional populations. Journal of Drug Issues, 34, 451-480.
64. Springer, S. A., & Bruce, P. D. (2008). A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV infected prisoners. Journal of Opioid Management, 4 (2), 81-86.
65. Stallwitz, A., & Stover, H. (2007). The impact of substitution treatment in prisons: A literature review. International Journal on Drug Policy, 18, 464-474.
66. Taxman, F. S., Perdoni, M., & Harrison, L. D. (2007). Drug treatment services for adult offenders: The state of the state. Journal of Substance Abuse Treatment, 32, 239-254.
67. Tomasino, V., Swanson, A. J., Nolan, J., & Shuman, M. (2001). The Key Extended Entry Program (KEEP): A methadone treatment program for opiate-dependent inmates. The Mount Sinai Journal of Medicine, 68, 14-20.
68. Tucker, J. A., & Roth, D. L. (2006). Extending the evidence hierarchy to enhance evidence-based practice for substance use disorders. Addiction, 101, 918-932.
69. Wexler, H. K., & Prendergast, M. L. (2010). Therapeutic communities in United States' prisons: Effectiveness and challenges. Therapeutic Communities, 31, 157-175.
70. Zanis, D., Coviello, D., Lloyd, J. J., & Nazar, B. L. (2009). Predictors of drug treatment completion among parole violators. Journal of Psychoactive Drugs, 41, 173-180.